PlainRecalls
FDA Drug Moderate Class II Ongoing

Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use Only, Rx only, 3801 Mojave Ct. Suite 101, Columbia, MO 65202, NDC 71170-950-25

Reported: April 5, 2023 Initiated: February 8, 2023 #D-0487-2023

Product Description

Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use Only, Rx only, 3801 Mojave Ct. Suite 101, Columbia, MO 65202, NDC 71170-950-25

Reason for Recall

Lack of assurance of sterility: Suspected microbial growth present on external label packaging.

Details

Recalling Firm
Apollo Care
Units Affected
215 bags
Distribution
MO
Location
Columbia, MO

Frequently Asked Questions

What product was recalled?
Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use Only, Rx only, 3801 Mojave Ct. Suite 101, Columbia, MO 65202, NDC 71170-950-25. Recalled by Apollo Care. Units affected: 215 bags.
Why was this product recalled?
Lack of assurance of sterility: Suspected microbial growth present on external label packaging.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 5, 2023. Severity: Moderate. Recall number: D-0487-2023.